Reconstitution of human hypoxia inducible factor HIF-1 in yeast:: A simple in vivo system to identify and characterize HIF-1α effectors

被引:9
作者
Braliou, Georgia G. [1 ]
Venieris, Emmanouil [1 ]
Kalousi, Alkmini [1 ]
Simos, George [1 ]
机构
[1] Univ Thessaly, Sch Med, Biochem Lab, Larisa 41222, Greece
关键词
HIF-1; alpha; ARNT; yeast; hsp90; geldanamycin; radicicol; sbal; Sti1; Cpr6;
D O I
10.1016/j.bbrc.2006.06.043
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hypoxia inducible factor I (HIF-1), the master regulator of hypoxia-activated genes, is involved in many diseases and is a valid drug target. In order to develop a simple and genetically tractable in vivo system for HIF-1 analysis, we tested the inducible expression of both human HIF-1 subunits (HIF-1 alpha and ARNT) in the yeast Saccharomyces cerevisiae and showed the formation of transcriptionally active HIF-1. The use of this system for the identification and characterization of HIF-1 effectors was first validated by showing that two chemical Hsp90 inhibitors, geldanamycin and radicicol, impaired the activity of HIF-1 in yeast. By applying this system in mutant yeast strains. we then identified Hsp90 co-chaperones, which were required for HIF-1 activity. Furthermore, using yeast strains co-expressing truncated forms of HIF-1 alpha with ARNT or both HIF-1 alpha and ARNT, we characterized fragments of HIF-1 alpha that acted as dominant negative mutants and suppressed HIF-1 activity. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:1289 / 1296
页数:8
相关论文
共 34 条
[1]   Signalling via the hypoxia-inducible factor-1α requires multiple posttranslational mofications [J].
Brahimi-Horn, C ;
Mazure, N ;
Pouysségur, J .
CELLULAR SIGNALLING, 2005, 17 (01) :1-9
[2]   Antifungal activities of antineoplastic agents Saccharomyces cerevisiae as a model system to study drug action [J].
Cardenas, ME ;
Cruz, MC ;
Del Poeta, M ;
Chung, NJ ;
Perfect, JR ;
Heitman, J .
CLINICAL MICROBIOLOGY REVIEWS, 1999, 12 (04) :583-+
[3]   Cobalt induces hypoxia-inducible factor-1α expression in airway smooth muscle cells by a reactive oxygen species- and PI3K-dependent mechanism [J].
Chachami, G ;
Simos, G ;
Hatziefthimiou, A ;
Bonanou, S ;
Molyvdas, PA ;
Paraskeva, E .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2004, 31 (05) :544-551
[4]   In vivo analysis of the Hsp90 cochaperone Sti1 (p60) [J].
Chang, HCJ ;
Nathan, DF ;
Lindquist, S .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (01) :318-325
[5]   Hsp90: the vulnerable chaperone [J].
Chiosis, G ;
Vilenchik, M ;
Kim, J ;
Solit, D .
DRUG DISCOVERY TODAY, 2004, 9 (20) :881-888
[6]   Pharmacological and genetic analysis of 90-kDa heat shock isoprotein-aryl hydrocarbon receptor complexes [J].
Cox, MB ;
Miller, CA .
MOLECULAR PHARMACOLOGY, 2003, 64 (06) :1549-1556
[7]   The p23 co-chaperone facilitates dioxin receptor signaling in a yeast model system [J].
Cox, MB ;
Miller, CA .
TOXICOLOGY LETTERS, 2002, 129 (1-2) :13-21
[8]   A cyclophilin function in Hsp90-dependent signal transduction [J].
Duina, AA ;
Chang, HCJ ;
Marsh, JA ;
Lindquist, S ;
Gaber, RF .
SCIENCE, 1996, 274 (5293) :1713-1715
[9]   SBA1 encodes a yeast Hsp90 cochaperone that is homologous to vertebrate p23 proteins [J].
Fang, YF ;
Fliss, AE ;
Rao, J ;
Caplan, AJ .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (07) :3727-3734
[10]   HIF-1 as a target for drug development [J].
Giaccia, A ;
Siim, BG ;
Johnson, RS .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (10) :803-811